Specific Allergen Immunotherapy in Otorhinolaryngology Practice

Rate this item
(0 votes)

Abstract

Allergen specific immunotherapy is the practice of administering increasing doses of an allergen to an allergic patient in order to reduce symptoms on subsequent exposure. The exact mechanism of action is unclear. It is thought to invoke a state of immune unresponsiveness among peripheral T-cells and a subsequent shift from the allergic type immune response to the non-allergic type. Immunotherapy is highly effective in reducing symptoms and medication need, and also improves objective measures of nasal allergy. Traditional subcutaneous administration can rarely lead to severe systemic reactions, but it is now being superseded by sublingual immunotherapy, which appears to be as effective but with less risk. This article reviews the immunological basis of immunotherapy and its clinical applications.

Additional Info

Read 1188 times Last modified on Tuesday, 10 December 2013 11:23

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

Search

Member Login

          Forgot login? | Register

BBC News Feed

Get in touch

Tel:
+44 207 637 3544

Email:
This email address is being protected from spambots. You need JavaScript enabled to view it.

Address:
The Otorhinolaryngologist,
73 Newman Street, London
W1T 3EJ, 
UK

 

Rila Publications Ltd Ethics Policy